center for genetics and society · the center for genetics and society formal-ly opened its doors...
TRANSCRIPT
CENTER FORGENETICS AND
SOCIETY
2004 ANNUAL REPORT
2
INTRODUCTION
The Center for Genetics and Society is
pleased to present its Annual Report for
2004. This year has been our most active to date,
and displayed an important new level of policy
engagement.
Most significantly, CGS initiated discussions
with pro-choice and other progressive organiza-
tions in California concerning the serious flaws
inherent in Proposition 71, the $3 billion Stem
Cell Research and Cures Initiative, and went on
to provide key leadership in opposing the meas-
ure. It was clear from the beginning that the
measure was likely to pass, but we knew that its
flaws would soon come to light and could serve
to demonstrate why greater public oversight of
the biotech industry is urgently needed.
In May CGS held the ground-breaking confer-
ence, Gender and Justice in the Gene Age, at the
Ford Foundation in New York City. This con-
ference led to the establishment two months
later of CGS’s Gender, Justice and Human
Genetics Program.
In addition, we organized a series of well-
attended symposia addressing the need for a
broad civil society initiative addressing the new
human genetic technologies, culminating in
December with the symposium in New York
City on The Next Four Years, the Biotech Agenda,and the Human Future, which attracted over 400
participants.
Our press and media presence continued to
expand this year, as did traffic on our website.
We look forward to 2005, fully aware of the
magnitude of the task before us, yet confident
that a human future will prevail.
OUR MISSION
The Center for Genetics and Society is a
nonprofit information and public affairs
organization working to encourage responsi-
ble uses and effective societal governance of
the new human genetic and reproductive
technologies. We support benign and benefi-
cent medical applications of these technolo-
gies, and oppose those applications that
objectify and commodify human life and
threaten to divide human society. We work
in a context of support for the equitable pro-
vision of health technologies domestically
and internationally; for women’s health and
reproductive rights; for the protection of our
children; for the rights of the disabled; and
for precaution in the use of powerful new
technologies.
OUR HISTORY
After several years of exploratory activity
the Center for Genetics and Society formal-
ly opened its doors in October 2001. It was
founded by socially concerned academics,
civil society leaders and others in Northern
California. The Center focused its early
work on alerting key civil society con-
stituencies to the challenges posed by the
new human genetic technologies. We subse-
quently became active in the policy arena,
working with state elected officials, mem-
bers of Congress and United Nations dele-
gates, in support of responsible policies.
In 2004 the Center for Genetics and Society
played the leading role in organizing pro-choice
and progressive supporters of embryonic stem
cell research in opposition to California Ballot
Proposition 71, the Stem Cell Research and Cures
Initiative. Although, as widely expected, the measure
passed, our active opposition alerted many people to
the need to pay closer attention to human biotechnol-
ogy issues, and established CGS as a leading authori-
tative voice.
In the course of our campaign activities, CGS:
• Prepared and publicized the first detailed
critical analysis of Proposition 71. Our web-
page containing the analysis received over
1300 visits during the campaign, and
received 1200 more before the end of 2004.
• Assisted in the organization of the Pro-
Choice Alliance Against Proposition 71, the
statewide progressive network opposing the
initiative.
• Recruited and helped place op-eds in opposi-
tion to Proposition 71 in the San FranciscoChronicle, the Los Angeles Times, the San DiegoUnion-Tribune, and the Wall Street Journal.
• Was cited in over sixty news articles, and
debated Proposition 71 supporters on radio,
on television, and at public events.
• Organized a telephone press conference with
leading experts that drew reporters from out-
lets including the New York Times, the LosAngeles Times, USA Today, Newsday, the WallStreet Journal, and the Sacramento Bee.
• Worked with professional campaign consult-
ants to send 66,000 email messages and place
175,000 phone calls to targeted registered
Democrats in the final days of the campaign.
After passage of the initiative on November 2, CGS
announced that it would begin organizing to hold the
newly established stem cell program accountable to
the public interest. In December, public interest
attorney and CGS colleague Charles Halpern noti-
fied the California Attorney General that the agenda
announced for the first meeting of the stem cell gov-
erning board was in violation of California’s Open
Meeting Act. On the advice of the Attorney General,
the governing board directed that all agenda items
but one—election of the new chair—be suspended
pending adequate public notice. CGS representatives
testified during the course of the meeting and were
quoted in reports by the New York Times, Reuters, AP,the San Francisco Chronicle and Wired.
Questions and concerns about the new stem cell pro-
gram continued to mount, even among those who
originally supported the initiative. Democratic legisla-
tors have introduced bills addressing the initiative’s
flaws, key newspapers have editorialized about their
reservations, and news headlines critical of the initia-
tive have become routine.
Even as the flaws in Proposition 71 became evident,
however, biotech and biomedical interests in other
states—including New York, Massachusetts,
Wisconsin, Illinois, Pennsylvania and New Jersey—
began lobbying for public funding of their own stem
cell research programs. In response, CGS and allied
organizations began laying the groundwork for a
national campaign for responsible governance of stem
cell research and other new genetic technologies.
CGS wants to acknowledge the many others who
worked hard on this effort, including Loni Andrews,
George Annas, Diane Beeson, Paul Billings, Deborah
Burger, Daniel Callahan, Francine Coeytaux, Chris
Desser, Alexander Gaguine, Charles Halpern, Greg
Fawcett, Susan Berke Fogel, Terry Francke, Debra
Greenfield, Mitch Kapor, Freda Kapor Klein, Doug
Linney, Vicki Michel, Stuart Newman, Michael
Nolan, Judy Norsigian, Adrienne Pine, Daniel
Sarewitz, Pete Shanks, Susan Stephenson, Tina
Stevens, and David Winickoff.
POLICY ENGAGEMENT AND SPECIAL INITIATIVES
During 2004 the Center launched a major policy initiative opposing California’s Proposition 71 and working forresponsible implementation of it; established our program on Gender, Justice and Human Genetics; and continuedour work to “reframe the debate” over human genetic technologies.
PROPOSITION 71, THE CALIFORNIA STEM CELL INITIATIVE
3
4
GENDER, JUSTICE AND HUMAN GENETICS
In August 2004 CGS initiated its program on
Gender, Justice and Human Genetics (GJHG)
and hired its first director, Sujatha Jesudason.
The purpose of the program is to build and deepen
the capacity of feminist and social justice con-
stituencies, nationally and internationally, to frame,
advocate for and win policies that protect and
expand the human rights and health of women, chil-
dren and communities of color as they are affected
by the new human genetic and reproductive tech-
nologies.
The seeds for this program were sown at a historic
meeting of feminists and social justice activists in
May 2004 in New York, Gender and Justice in theGene Age. Working in collaboration with Our Bodies
Ourselves and the Committee on Women, Population
and the Environment, CGS hosted a meeting of 65
feminist leaders to grapple with the tensions and con-
tradictions of the new reproductive and genetic tech-
nologies, and to chart a path that will protect
women’s health, access to abortion and uncoerced
reproductive options, and allow for responsible social
governance. Out of the rich debate, discussion and
exchange of ideas that occurred at this meeting, it
was decided that GJHG will focus initially on four
areas of activism: Sex Selection, Eugenics, Human
Rights, and Reproductive Health.
The Sex Selection initiative will campaign to stop
the current use and marketing of sex selection in
the United States and internationally. During 2004
CGS convened the first meetings of our initial col-
laborative partners in this effort: the National Asian
Pacific American Women’s Forum, the Committee
on Women, Population and the Environment, and
Manavi, a South Asian domestic violence preven-
tion organization.
The Eugenics Past, Present and Future initiative will
demonstrate the connection between eugenic and
genocidal practices and ideologies in the past, cur-
rent discriminatory practices, and proposals for the
creation of “superior humans” through genetic modi-
fication. In 2004 CGS held the first planning meet-
ings with our collaborative partners in this initiative:
SisterSong, a national women of color reproductive
and sexual health and rights organization, and the
World Institute on Disability.
Preliminary discussions were held regarding the
Human Rights initiative, which will work with
human rights activists to develop a human rights
framework for evaluating applications of new human
genetic technologies.
CGS opposes marketing of “sex selection” technologies,such as this ad in the New York Times.
May 2004: Feminist and social justice leaders gather for“Gender and Justice in the Gene Age” at the Ford Foundation, New York City.
5
In the area of reproductive health, CGS will continue
its work with pro-choice, feminist and women’s
health organizations. Marcy Darnovsky and Sujatha
Jesudason briefed the California Coalition for
Reproductive Freedom on the pro-choice and
women’s health implications of the new technologies.
They assisted the coalition in forming a new
Reproductive Technologies subcommittee to inform
their understanding of the challenges faced with the
new developments of these technologies. As an
Advisory Committee member, Sujatha assisted in the
formation of an Assisted Reproduction/Technologies
section at the upcoming Reproductive Justice for All: AUS Policy Conference hosted by Smith College and
Planned Parenthood Federation of America.
Additionally, Sujatha and Marcy briefed key leader-
ship of Planned Parenthood of New York City on
upcoming challenges of these technologies to pro-
choice organizations in the near future.
REFRAMING THE DEBATE
To date most debate over policies concerning new
human genetic technologies has been dominated by
two polarized constituencies: religious fundamental-
ists, who generally want across-the-board bans on
research involving human embryos, and the biotech
industry and biomedical community, which resists
even reasonable social oversight and control.
Struggles over human genetic research have come to
be seen as surrogates for struggles over abortion
rights. This polarization has resulted in policy grid-
lock at many levels of government.
In 2004 CGS initiated a series of events designed to
promote an alternative position on human genetic
technology issues, one that does not reject these tech-
nologies in principle, but that calls for strong restric-
tions on their socially unacceptable applications.
These events included a July 12 symposium at The
Century Foundation in New York City attended by
nearly 130 people, a September 28 public colloquium
sponsored by the U.C. Berkeley School of
Journalism that attracted nearly 100 people, and a
major December 9 symposium at the City University
of New York Graduate Center attended by over 400.
These events were co-sponsored by noted liberal
organizations, and organized with special regard to
reaching liberal audiences. We are planning an
expanded series of activities designed to “reframe the
debate” during 2005.
Websites and CDsproduced to support major
CGS conferences areconfigured to serve as on-going
post-conference resources.
6
January 17-20: In cooperation with Friends of the
Earth and the Association for Women’s Rights in
Development, CGS Program Director Jesse
Reynolds organized three workshops presenting
seven speakers at the 3rd Annual World SocialForum held in Mumbai, India. The workshops
addressed a full range of issues, including sex selec-
tion, gender equality, the biotech industry and glob-
alization, and international governance of genetic
technologies.
February 2-6: CGS International Associate Rosario
Isasi conducted a round of meetings in Peru,
including a presentation to the Peruvian Bioethics
Association, meetings with the Peruvian Office of
Social Research and the Andean Interdisciplinary
Studies Seminar, and radio interviews. Plans were
discussed for a subsequent lecture series in Peru, and
other activities.
March 13: CGS Associate Executive Director Marcy
Darnovsky was invited to organize and speak on a
panel at Boundaries in Question: New FeministPerspectives on Biotechnology and Bioethics, held at
the University of California at Berkeley.
April 27-29: Rosario Isasi represented CGS at the
Extraordinary Session Towards a Declaration onUniversal Norms on Bioethics convened by the
UNESCO International Bioethics Committee, in
Paris. She was joined by colleagues from the
Heinrich Böll Foundation, the Institut Mensch,
Ethik und Wissenschaft, and Disability Rights
International, among others.
May 6-7: Gender and Justice in the Gene Age: AFeminist Meeting on New Reproductive and GeneticTechnologies. Some sixty-five people—feminist, social
justice, women’s health, disability, and human rights
activists, academics, writers and others—met in New
York City at the Ford Foundation to work toward a
framework for assessing new reproductive and
genetic technologies from a social justice perspective.
The event was co-sponsored by CGS, the Committee
on Women, Population and the Environment, and
Our Bodies Ourselves.
May 20: Marcy Darnovsky presented an overview of
our perspectives at a meeting of the NationalAdvisory Board, a coalition of women’s groups
working against religious restrictions on healthcare
and medical research, in Los Angeles, California.
June 1: CGS Executive Director Richard Hayes pre-
sented and discussed our perspectives at a meeting of
bioethics scholars at the Institute for AdvancedStudy in Princeton, New Jersey.
CONFERENCES, MEETINGS, WORKSHOPS, SYMPOSIA
CGS Project Director Jesse Reynolds presenting at theWorld Social Forum, Mumbai, India, January 17-20.
The Center’s initial focus on alerting key civil society constituencies to the challenges posed by the new humangenetic technologies remains a key element of our work. Major conferences, meetings, workshops, symposia andother events which we initiated, or in which we played key roles, are shown below.
CGS Associate Director Marcy Darnovsky speaking at theNext Four Years symposium, New York City, December 9.
7
June 4-5: Jesse Reynolds and Marcy Darnovsky
were speakers at the Reclaiming the Commons Teach-In in San Francisco held in conjunction with the
Annual Convention of the Biotechnology Industry
Organization (BIO). Issues they addressed included
biotech barriers to medical justice, feminism and
reproductive rights, and the politics of the new
human genetic technologies.
July 9: Marcy Darnovsky spoke on the panel Whatis Wrong with Remaking Human Nature? at the
Communitarian Summit held in Washington DC,
along with George Annas (Boston University),
Arthur Caplan (University of Pennsylvania) and
Ezekiel Emmanuel (National Institutes of Health),
with Amitai Etzioni (George Washington University)
as host and moderator.
July 15: Inequality, Democracy, and the New HumanBiotechnologies. Nearly 130 participants gathered for
this symposium at the The Century Foundation in
New York City to hear Marsha Darling (Adelphi
University), Sheldon Krimsky (Tufts University),
Susan Lindee (University of Pennsylvania) and
Richard Hayes (CGS) discuss the challenges to
equality and democracy posed by new human
biotechnologies. The event was co-sponsored by
CGS, Demos, and The Century Foundation.
August 14: CGS convened a side meeting of partici-
pants at the annual meeting of the AmericanSociology Association in San Francisco to explore
their interest in furthering debate over the social con-
sequences of the new human genetic technologies.
September 28: Humans 2.0: Will Your GrandchildrenBe Genetically Modified? A Conversation on the Socialand Political Implications of the New HumanBiotechnologies. Author Bill McKibben and Marcy
Darnovsky were joined by host Michael Pollan,
Director of U.C. Berkeley’s Knight Program in
Science and Environmental Journalism, to consider
the impact that the new human genetic and repro-
ductive technologies could have on human society.
Nearly 100 people attended. The event was later
aired on KPFA radio.
October 22: CGS held a half-day meeting of New
York City scholars and activists to discuss ways to
bring issues concerning the new human genetic tech-
nology to the attention of liberals and progressives.
October 22-23: Sujatha Jesudason was a speaker in
Mexico City at the Heinrich Böll Foundation’s
Conferencia Sobre Biopolitica 2004—Privatización dela Naturaleza y del Conocimiento—Bajo el signoBIOS: tecnología, ética, diversidad y derechos. She
briefed reporters on social justice and feminist con-
cerns with cloning, human genetic modification and
reproductive and genetic technologies, and presented
on issues of “Justice in the Gene Age.”
October 27: CGS held a press conference on pro-
choice opposition to Proposition 71. Participants
were Marcy Darnovsky (CGS), Paul Billings (U.C.
Berkeley), Deborah Burger (California Nurses
Association), and Francine Coeytaux (Pro-Choice
Alliance Against Proposition 71).
Over 400 participants at theDecember 9 symposium in New York.
Dorothy Roberts of Northwestern Universityspeaking at the December 9 symposium.
8
November 8-11: CGS, in cooperation with the
Heinrich Böll Foundation, presented a Special
Symposium and a workshop, and held several side
meetings, collectively titled New Voices, NewPerspectives: Towards a Global Consensus on the NewHuman Genetic Technologies, at the meetings of the
World Congress of Bioethics and FeministApproaches to Bioethics in Sydney Australia. Over
eighty people attended the various CGS/HBS events.
Presenters at the events were George Annas (USA),
Marsha Tyson Darling (USA), Anita Ghai (India),
Richard Hayes (USA), Emilia Ianeva
(Bulgaria/USA), Rosario Isasi (Peru/Canada),
Sujatha Jesudason (USA), Rupsa Mallik (India),
Roxanne Mykitiuk (Canada), Merry Osemwegie
(Nigeria/UK), Andreas Poltermann (Germany), and
René Segbenou (Benin).
November 30: Marcy Darnovsky and Sujatha
Jesudason briefed the Reproductive Technologies
Committee (formed this year at their suggestion) of
the California Coalition for Reproductive Freedomon the “New Science, Politics and Policies of
Reproductive and Genetic Technologies.”
December 8: Sujatha Jesudason organized the first
leadership meeting, in New York City, of the develop-
ing campaign against sex selection. Collaborative
members include: National Asian Pacific American
Women’s Forum, Committee on Women, Population
and the Environment, and Manavi, a South Asian
domestic violence prevention organization.
December 9: Over 400 attendees heard Sheldon
Krimsky (Tufts University), Dorothy Roberts
(Northwestern University), William Saletan (Slate),
Stuart Newman (NY Medical College) and Marcy
Darnovsky (CGS) make the case for socially respon-
sible policies governing the new human genetic tech-
nologies at The Next Four Years, the Biotech Agendaand the Human Future: What Direction for Liberaland Progressives? The symposium was held at the
Graduate Center of the City University of New
York, and co-sponsored by CGS, the Graduate
Center CUNY, the Nation Institute, Demos, and the
New York Open Center.
December 10: At the request of Planned ParenthoodNYC, Marcy Darnovsky and Sujatha Jesudason
presented and discussed our perspectives at a leader-
ship briefing there.
Other activities
In 2004 CGS staff participated in a number of key con-
ferences and events. Rosario Isasi attended the Sept.
30-Oct. 1 First Annual Conference on Ethics, Science andMoral Philosophy of Assisted Human Reproduction; the
October 12-13 National Academies of Science work-
shop in Washington, DC on Guidelines for HumanEmbryonic Stem Cell Research: A Public Workshop; and the
October 16-17 meeting of the United Nations Sixth
Committee addressing the UN cloning declaration
process. Richard Hayes participated in the December
16 meeting on Babies by Design, sponsored by the
Genetics and Public Policy Center, in Washington, DC.
CGS Executive Director Richard Hayes.
9
COMMUNICATIONS
ABC7 Evening NewsAssociated Press (4)
Christian Science Monitor (2)
Cimac Noticias (2)
Contra Costa Times (2)
Criterios.com
East Bay ExpressGrupo ReformaKGO TV Beyond the HeadlinesKPFA Morning ShowKPFA Sunday SalonKQED Forum (2)
KWMR America Off-Line
Los Angeles Times (3)
Mujeres HoyNatureNew York TimesNewsdayNorth County Times Oakland Tribune group
(4 papers) (5)
Osgood Files Pacific SunRed HerringReuters (2)
Sacramento Bee (5)
San Diego Union Tribune (6)
San Francisco Bay Guardian San Francisco Business Times (2)
San Francisco Chronicle (8)
San Francisco ExaminerSan Jose Mercury News (4)
ScienceSFSU XpressSilicon Valley MetroSlateStanford Medicine MagazineUSA TodayWBAI Wake Up CallWired
CGS’s electronic newsletter, Genetic Crossroads, isdelivered approximately every other month to over
3500 subscribers. Subscriptions are up 10% from
2003, mostly due to more than 300 voluntary on-line
subscriptions. In 2004 the newsletter underwent a
significant redesign, improving both visual impact
and readability.
Unique visitors to the CGS website now typically
number approximately 50,000 per month. On aver-
age, each month in 2004 saw a 29% increase in the
number of unique visitors over the same month in
2003. Our home page was redesigned, and sections
on the California stem cell initiative and related top-
ics were added, as were versions of key documents in
Russian.
CGS produced two high-quality CDs, containing
hundreds of pages of resource materials each, for dis-
tribution at the World Congress of Bioethics /
Feminist Approaches to Bioethics, and at the Dec. 9
NYC symposium on The Next Four Years, the BiotechAgenda, and the Human Future.
• Jesse Reynolds, “Stem Cell Cronyism,”
San Francisco Bay Guardian (December 29, 2004)
• Richard Hayes, “Breaking the policy deadlock on
cloning and assisted reproduction,”
San Francisco Chronicle (April 4, 2004)
• Richard Hayes, “Selective Science,”
TomPaine.Com (February 12, 2004)
• Marcy Darnovsky, “High-Tech Sex Selection:
A New Chapter in the Debate,”
GeneWatch (Vol. 17, No. 1, January 2004)
CGS staff were quoted, cited, or interviewed on over seventy occasions during 2004, in the following outlets
(parentheses = number of different stories):
Other Press and Media Appearances by CGS, 2004
Published Articles, 2004
Publications and Resources
CGS currently has six staff:
• Executive Director Richard Hayes, Ph.D., served
for many years on the national staff of the Sierra
Club and as a political organizer with the
Democratic Party and a wide range of social justice
organizations.
• Associate Executive Director Marcy Darnovsky,
Ph.D., has taught courses on the politics of science
and technology at the Hutchins School of Liberal
Studies at California State University, Sonoma, and
has long been active on social justice and environ-
mental issues in California.
• Program Director Sujatha Jesudason, M.A., is a
doctoral candidate at the University of California,
Berkeley, and worked for many years in behalf of
the rights of immigrants, people of color and work-
ing women.
• Project Director Jesse Reynolds, M.S., served as a
US EPA Fellow and helped organize Students for
Responsible Research at the University of
California, Berkeley, focused on corporate-univer-
sity relations.
• International Associate Rosario Isasi, J.D.,
M.P.H., has worked on international human rights,
mental health and anti-torture initiatives, and is
currently a post-doctoral fellow at the University of
Montreal’s Program on Genetics and Society.
• Administrative Assistant Jasmine Gonzales, B.A.,
has worked for immigrant and refugee rights and
other social and economic justice concerns.
Organizational StatusCGS is currently a project of the Tides Center. We are in the process of forming a board of directors and
plan to incorporate as an independent 501(c)3 organization during 2005.
During 2004 CGS received $609,500 in income, spent $539,899 on program and administrative activities, andaugmented its cash reserve. CGS has income of $650,000 committed for 2005 and hopes to raise at least another$250,000. CGS’ funding history is shown here:
10
STAFF
Year Total Funds Raised/Committed
2000 $165,700
2001 $329,500
2002 $392,400
2003 $620,000
2004 $609,500
2005 $650,000 *
* committed
CGS Funding History
FINANCES
CGS staff: Marcy Darnovsky,Sujatha Jesudason, Richard Hayes,Jasmine Gonzales, Jesse Reynolds.
Insert: Rosario Isasi.
CGS gratefully acknowledges its past and currentdonors:Appleton Foundation, CS Fund/Warsh-Mott
Legacy, Changing Horizons Fund, Foundation for
Deep Ecology, Marisla Foundation, StarFire Fund,
Aurora Foundation, Jennifer Altman Foundation,
French American Charitable Trust, Pettus-Crowe
Foundation, Heinrich Böll Foundation, Ahimsa
Fund, Tides Foundation, Ms Foundation, and indi-
vidual and anonymous donors. In-kind support has
been provided by Public Media Center.
11
Jan. 26-31: World Social Forum, Porto Alegre, Brazil. Program
Director Sujatha Jesudason is invited by the Brazil
Office of the Heinrich Böll Foundation to present at
a workshop on the “The Biopolitics of Life: The
Privatization of Life and Knowledge.” She will be
speaking on “(Re)creating Life—Ethical, Social and
Gender Aspects about New Human Genetic
Technologies.”
Feb 25-27: Women Coming Together: Claiming the Law for SocialChange, at the University of Cincinnati and spon-
sored by the Ford Foundation. Sujatha Jesudason
will present on a panel on “Emerging Issues in
Reproductive Health: Impact of Ideology and
Technology on Women’s Access and Rights.”
March 11-12:Incite! Color of Violence 3: Stopping the War onWomen of Color Conference, New Orleans. Sujatha
Jesudason will be presenting a workshop on
“Gender Based Violence of Biotechnology and Sex
Selection,” with collaborative partners Rajani Bhatia
from the Committee on Women, Population, and the
Environment, and Shamita Das Dasgupta of
Manavi, a South Asian domestic violence prevention
organization.
April 2-3: From Abortion Rights to Social Justice: Building theMovement for Reproductive Freedom, Hampshire
College, Amherst, MA. Marcy Darnovsky will be
speaking at a workshop and plenary session on the
new eugenics at this annual conference sponsored by
the Civil Liberties and Public Policy Program and
the Population and Development Program.
May:Publication of Rights and Liberties in the Biotech Age:Why We Need a Genetic Bill of Rights (Rowman &
Littlefield Publishers, Inc.), Sheldon Krimsky and
Peter Shorett, eds., including Marcy Darnovsky’s
chapter on “A Human Rights Framework for
Understanding the New Human Genetic
Technologies.”
Sept. 21-25: Health Rights, Women’s Lives: Challenges &Strategies for Movement Building, the 10th
International Women and Health Meeting, New
Delhi, India. Sujatha Jesudason and colleagues will
present on their campaign to regulate and stop the
marketing and use of sex selection in the U.S., and
their work with collaborative partners in India and
China.
Oct 27-30:How Does Change Happen? The 10th Association ofWomen’s Rights in Development International Forum,Bangkok, Thailand. Sujatha Jesudason and collabo-
rative partners will discuss their campaign address-
ing social sex selection in the U.S., and their work
with other organizations in India and China.
Nov. 10-13: Reproductive Justice for All: Designing Policies toSecure Equality in the U.S., a conference organized
by Planned Parenthood Federation of America and
Smith College. Sujatha Jesudason will speak at a
plenary about the policy challenges and opportunities
of regulating reproductive and genetic technologies.
2005 AND BEYOND
We anticipate that 2005 will be even more intense than 2004 has been. Controversies concerning
the new human genetic technologies are coming to public attention with increasing frequency,
and financial and corporate forces are playing a steadily greater role. During 2005 we intend to
build a solid base of activism in the three program areas of Biotech Accountability, Gender and Justice, and
Reframing the Debate. Senior staff will devote special attention to fundraising, to ensuring a smooth transi-
tion to our status as an independent 501(c)3, and to recruiting allies among national and international organi-
zations and individuals. CGS activities already confirmed for 2005 include:
436 14th Street, Suite 1302
Oakland, CA 94612
www.genetics-and-society.org
tel. 510-625-0819
fax. 510-625-0874
Design by Design Action Collective
CENTER FOR
GENETICS AND
SOCIETY